期刊文献+

联合基因沉默TLR2、4对于LPA诱导的RASMCs表型转化的影响

Effects of joint gene silence of TLR2 and TLR4 on LPA induced phenotypic modulation of RASMCs
下载PDF
导出
摘要 目的应用RNA干扰技术单一或者联合沉默Toll样受体(TLR)2、4基因,探讨其在溶血磷脂酸(LPA)诱导的平滑肌细胞(VSMCs)表型转化中的作用。方法根据文献建立分化表型大鼠VSMCs(RASMCs)培养体系,予TLR2、4特异性小干扰RNA(siRNA)转染RASMCs,LPA 1μmol/L处理4h后,荧光定量RT-PCR法、Western blot法检测分化和去分化细胞表型标志基因平滑肌肌动蛋白(SMA-α)和骨桥蛋白(OPN)基因及蛋白水平的表达。结果 TLR2、4-siRNA分别转染细胞后可显著抑制LPA诱导的RASMCs细胞SMA-α基因、蛋白下调及OPN基因、蛋白上调,TLR2、4联合干扰组对于LPA诱导的RASMCs细胞SMA-α基因、蛋白下调及OPN基因、蛋白上调的抑制作用较TLR2、4单独干扰组进一步加强。结论 TLR2、4信号通路参与了LPA诱导的表型转化,联合干预TLR2、4,有可能成为稳定动脉粥样硬化斑块、抗粥样硬化治疗的一个新途径之一。 Objective To apply the RNA interference technology to singly or jointly to silence toll-like receptor(TLR)-2,4genes and to investigate their effects on lysophosphatidic acid(LPA)induced phenotypic modulation of vascular smooth muscle cells(VSMCs).Methods The culture system of rat aortic smooth muscle cells(RASMCs)in differentiated phenotype rats was established according to the literature.Then TLR-2and TLR 4specially small interference RNA(TLR2-siRNA,TLR4-siRNA)were tranfected into RASMCs.After the treatment by 1μmol/L of LPA for 4h,the gene and protein levels of SMA-αand OPN as the marker genes for VSMC differentiated and dedifferentiated phenotype were detected by real-time quantitative RT-PCR and Western blot respectively.Results TLR2-siRNA and TLR4-siRNA transfection could significantly inhibit the down-regulation of SMA-αgene and protein,and the up-regulation of OPN gene and protein in LPA induced RASMCs,the inhibiting effect of the joint interference of TLR2 and TLR4on the down-regulation of SMA-αgene and protein,and the up-regulation of OPN gene and protein in LPA induced RASMCs was further strengthened than the single interference of TLR2 and TLR 4.Conclusion The TLR2 and TLR4signal pathway participates in the LPA-stimulated phenotypic modulation of RASMCs.The joint intervention on TLR2 and TLR4might become one of new pathway for stabilizing atherosclerotic plaque and anti-atherosclerotic therapy.
出处 《重庆医学》 CAS 北大核心 2016年第4期448-450,453,共4页 Chongqing medicine
基金 湖北省卫生厅科研指导性项目(JX6C-19) 湖北省教育厅科学技术研究计划优秀中青年人才项目(Q20121117)
关键词 TOLL样受体 RNA干扰 溶血磷脂素类 血管 肌细胞 平滑肌 表型转化 toll-like receptors RNA interference lysophospholipids blood vessels myocytes smooth muscle phenotypic modulation
  • 相关文献

参考文献15

  • 1Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and irnmuniry] ] ]. Immunity,2011 ,34(5): 637-650.
  • 2Lin YT, Verma A, Hodgkinson CPo Toll-like receptors and human disease: lessons from single nucleotide polymorphisms [J]. Curr Genomics. 2012,13(8): 633-645.
  • 3Raveendran VV, Tan X. Sweeney ME, et al. Lipopolysaccharide induces HI receptor expression and enhances histamine responsiveness in human coronary artery endothelial cells[J]. Immunology,2011 ,132(4) :578-588.
  • 4Hayashi K,Takahashi MvNishida W,et al. Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids[J]. Circ Res,2001 ,89(3): 251-258.
  • 5Shanahan CM, Weissberg PL. Metcalfe JC. Isolation of gene markers of differentiated and proliferating vascular smooth muscle cells[J]. Circ Res. 1993,73(1): 193-204.
  • 6牛建平,周志斌,宋叶华,林俊.溶血磷脂酸对人单核细胞株THP-1细胞核因子-κB表达的影响[J].中华脑血管病杂志(电子版),2013,7(5):1-3. 被引量:1
  • 7Cui MZ. I.ysophosphatidic acid effects on atherosclerosis and thrombosis[J]. Clin Lipidol, 2011, 6(4) :413-442.
  • 8Schober A,Siess W. Lysophosphatidic acid in atheroscle- rotic diseases[J]. Br J Pharmacol, 2012,167 (3): 465-482.
  • 9李小好,杨波,尚桂莲,周志斌.溶血磷脂酸受体3介导溶血磷脂酸诱导的血管平滑肌细胞表型转化[J].中华老年心脑血管病杂志,2012,14(10):1082-1086. 被引量:5
  • 10Hodgkinson cr. YeS. Toll-like receptors, their ligands. and atheroscierosis[J]. Sci World J,2011,14(11) :437-453.

二级参考文献19

  • 1Mack CP. Signaling mechanisms that regulate smooth muscle cell differentiation. Arterioscler Thromb Vase Biol, 2011,31:1495-1450.
  • 2Xie C,Ritchie RP, Huang H, et al. Smooth muscle cell differentiation in vitro: models and underlying molecular mechanisms. Arterioscler Thromb Vase Biol,2011,31:1485-1494.
  • 3Choi JW, Herr DR, Noguchi K et al. LPA receptors: subtypes and biological actions. Annu Rev Pharmacol Toxicol, 2010, 50:157-186.
  • 4Yoshida K,Niahida W, Hayashi K, et al. Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo. Circulation, 2003,108 : 1746-1752.
  • 5Zhang C,Baker DL,Yasuda S,et al. Lysophosphatidic acid in duces neointima formation through PPARgamma activation. J Ex Med, 2004,199 : 763-774.
  • 6Kim J, Keys JR, Eckhart AD. Vascular smooth muscle migration and proliferation in response to lysophosphatidic acid (LPA) is mediated by LPA receptors coupling to Gq. Cell Signal, 2006,18 : 1695-1701.
  • 7Hama K, Aoki J. LPA (3), a unique G protein-coupled receptor for lysophosphatidie acid. Prog Lipid Res, 2010,49:335- 342.
  • 8Beamish JA, He P, Kottke Marchant K, et al. Molecular regu lation of contractile smooth muscle cell phenotype: implica tions for vascular tissue engineering. Tissue Eng Part B Rev, 2010,16:467-491.
  • 9Brand K, Page S, Rogier G. Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion. J Clin Invest, 1996,97 (7):1715-1722.
  • 10Hansson GK, Hennansson A. The immune system in atherosclerosis. Nat Immunol, 2011, 12(3):204-212.

共引文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部